Deroy & Devereaux Private Investment Counsel’s REGENERX BIOPHARMACEUTICALS RGN Stock Holding History

Deroy & Devereaux Private Investment Counsel’s Portfolio RGN Stock Details RGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2013 Q4	–	Sell	-47,300	Closed	-$3K	–	187
2013 Q3	$3K	Sell	47,300 -11,600	-20%	-$736	﹤0.01%	159
2013 Q2	$5K	Buy	+58,900	New	+$5K	﹤0.01%	156

Other funds holding RGN

DBIA

Dumont & Blake Investment Advisors Princeton, New Jersey $445M AUM 31.98% 1-Year Est. Return

Deroy & Devereaux Private Investment Counsel's RGN Position: Q4 2013 in Review

Deroy & Devereaux Private Investment Counsel sold out of REGENERX BIOPHARMACEUTICALS (RGN) in Q4 2013, closing a stake of 47,300 shares — an estimated $3K sold.

Deroy & Devereaux Private Investment Counsel first reported a position in RGN in Q2 2013 and held it in 2 quarters. The position peaked at $5K in Q2 2013. 1 fund tracked by Wall St. Rank holds RGN as of Q4 2013.

Deroy & Devereaux Private Investment Counsel reported no remaining REGENERX BIOPHARMACEUTICALS position as of Q4 2013 after selling out during the quarter.
Deroy & Devereaux Private Investment Counsel sold 47,300 REGENERX BIOPHARMACEUTICALS shares in Q4 2013, an estimated $3K.
Deroy & Devereaux Private Investment Counsel first reported a position in REGENERX BIOPHARMACEUTICALS in Q2 2013 and held it in 2 quarters.
Deroy & Devereaux Private Investment Counsel's REGENERX BIOPHARMACEUTICALS position peaked at $5K in Q2 2013.
1 fund tracked by Wall St. Rank held REGENERX BIOPHARMACEUTICALS as of Q4 2013.

Based on Deroy & Devereaux Private Investment Counsel's 13F filing for Q4 2013, filed 22 Jan 2014.